Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Congenital sideroblastic anemia due to mutations in the mitochondrial HSP70 homologue HSPA9

Blood (2015) 126 (25): 2734–2738.

https://doi.org/10.1182/blood-2015-09-659854

Published: 2015

Includes: Supplemental data

Journal Articles

Cost and Utilization Of Stored Autologous PBSC To Support Tandem ASCT In MM Patients In The Era Of Novel Agent Therapy

Colin Phipps, MD, Michael L. Linenberger, MD, Damian J. Green, MD, M. Corinna Palanca-Wessels, MD, PhD, Pamela S. Becker, MD, PhD, Laura S. Connelly-Smith, MBBCh, DM, Nicholas Burwick, MD, Zandra K. Klippel, MD, William I. Bensinger, MD, Leona Holmberg, MD, PhD, Edward N. Libby, III, MD

Blood (2013) 122 (21): 4507.

https://doi.org/10.1182/blood.V122.21.4507.4507

Published: 2013

Journal Articles

The Dynamic International Prognostic Scoring System for myelofibrosis predicts outcomes after hematopoietic cell transplantation

Bart L. Scott, Ted A. Gooley, Mohamed L. Sorror, Andrew R. Rezvani, Michael L. Linenberger, Jonathan Grim, Brenda M. Sandmaier, David Myerson, Thomas R. Chauncey, Rainer Storb, Veronika Buxhofer-Ausch, Jerald P. Radich, Frederick R. Appelbaum, H. Joachim Deeg

Blood (2012) 119 (11): 2657–2664.

https://doi.org/10.1182/blood-2011-08-372904

Published: 2012

Journal Articles

Larger Numbers of Donor Naïve CD8+ T-Cells and Plasmacytoid Dendritic Cell Precursors In Allogeneic BM Grafts From Unrelated Donors Are Associated with Improved Survival: Results From BMT CTN 0201

Edmund K Waller, MD PhD, Wayne A.C. Harris, Steven Devine, David L. Porter, MD, Shin Mineishi, MD, John M. McCarty, MD, Corina E Gonzalez, MD, Thomas R Spitzer, MD, Oleg I. Krijanovski, PhD, MD, Michael L. Linenberger, MD, Ann Woolfrey, MD, Alan Howard, PhD, Cathy Gurgol, Brent R. Logan, PhD, Dennis L Confer, MD, Claudio Anasetti, MD

Blood (2011) 118 (21): 1004.

https://doi.org/10.1182/blood.V118.21.1004.1004

Published: 2011

Journal Articles

International Working Group Scores Predict Post-Transplant Outcomes In Patients with Myelofibrosis

Bart Lee Scott, MD, Ted A. Gooley, PhD, Michael L. Linenberger, MD, Brenda M. Sandmaier, MD, David Myerson, MD, Thomas Chauncey, MD, Frederick R. Appelbaum, MD, H. Joachim Deeg, MD

Blood (2010) 116 (21): 3085.

https://doi.org/10.1182/blood.V116.21.3085.3085

Published: 2010

Journal Articles

Effect of Peripheral Blood Stem Cell (PBSC) Graft Composition on Graft Versus Host Disease (GVHD) and Mortality After Allogeneic Transplantation

Shelly Heimfeld, PhD, Ted Gooley, Mary Flowers, MD, Frederic Baron, MD, PhD, Paul J. Martin, MD, Michael L. Linenberger, MD, Rainer F. Storb, MD, Frederick R. Appelbaum, MD, Brenda M. Sandmaier, MD

Blood (2010) 116 (21): 676.

https://doi.org/10.1182/blood.V116.21.676.676

Published: 2010

Journal Articles

The Effective Use of Plerixafor as a Real-Time Rescue Strategy for Patients with Poorly Mobilizing Autologous CD34+ Cells

Ajay K Gopal, MD, Mehdi Karami, PharmD, JoAL Mayor, PharmD, Mylene Macabeo, RN, Michael L. Linenberger, MD, William Bensinger, MD, Leona Holmberg, MD., PhD

Blood (2010) 116 (21): 2251.

https://doi.org/10.1182/blood.V116.21.2251.2251

Published: 2010

Journal Articles

Higher Doses of Transplanted T and B Cells Are Associated with Greater Incidence of Extensive Chronic GVHD after PBSC Transplantation from HLA-Identical Sibling Donors.

Frederic Baron, Brenda M. Sandmaier, Ted Gooley, Paul L. Martin, Mary E.D. Flowers, Michael L. Linenberger, Rainer F. Storb, Frederick R. Appelbaum, Shelly Heimfeld

Blood (2007) 110 (11): 1077.

https://doi.org/10.1182/blood.V110.11.1077.1077

Published: 2007

Journal Articles

Multidrug resistance protein attenuates gemtuzumab ozogamicin–induced cytotoxicity in acute myeloid leukemia cells

Roland B. Walter, Brian W. Raden, Tom C. Hong, David A. Flowers, Irwin D. Bernstein, Michael L. Linenberger

Blood (2003) 102 (4): 1466–1473.

https://doi.org/10.1182/blood-2003-02-0396

Published: 2003

Journal Articles

Multidrug-resistance phenotype and clinical responses to gemtuzumab ozogamicin

Michael L. Linenberger, Tom Hong, David Flowers, Eric L. Sievers, Ted A. Gooley, John M. Bennett, Mark S. Berger, Lance H. Leopold, Frederick R. Appelbaum, Irwin D. Bernstein

Blood (2001) 98 (4): 988–994.

https://doi.org/10.1182/blood.V98.4.988

Published: 2001

NARROW

Congenital sideroblastic anemia due to mutations in the mitochondrial HSP70 homologue HSPA9

Cost and Utilization Of Stored Autologous PBSC To Support Tandem ASCT In MM Patients In The Era Of Novel Agent Therapy

The Dynamic International Prognostic Scoring System for myelofibrosis predicts outcomes after hematopoietic cell transplantation

Larger Numbers of Donor Naïve CD8+ T-Cells and Plasmacytoid Dendritic Cell Precursors In Allogeneic BM Grafts From Unrelated Donors Are Associated with Improved Survival: Results From BMT CTN 0201

International Working Group Scores Predict Post-Transplant Outcomes In Patients with Myelofibrosis

Effect of Peripheral Blood Stem Cell (PBSC) Graft Composition on Graft Versus Host Disease (GVHD) and Mortality After Allogeneic Transplantation

The Effective Use of Plerixafor as a Real-Time Rescue Strategy for Patients with Poorly Mobilizing Autologous CD34+ Cells

Higher Doses of Transplanted T and B Cells Are Associated with Greater Incidence of Extensive Chronic GVHD after PBSC Transplantation from HLA-Identical Sibling Donors.

Multidrug resistance protein attenuates gemtuzumab ozogamicin–induced cytotoxicity in acute myeloid leukemia cells

Multidrug-resistance phenotype and clinical responses to gemtuzumab ozogamicin

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only